DTCCX
Price
$15.23
Change
+$0.02 (+0.13%)
Updated
Sep 20 closing price
VFIAX
Price
$527.71
Change
-$1.02 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

DTCCX vs VFIAX

Header iconDTCCX vs VFIAX Comparison
Open Charts DTCCX vs VFIAXBanner chart's image
BNY Mellon Sust US Equity C
Price$15.23
Change+$0.02 (+0.13%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Admiral
Price$527.71
Change-$1.02 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DTCCX vs VFIAX Comparison Chart
Loading...
VS
DTCCX vs. VFIAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTCCX is a Buy and VFIAX is a Buy.

FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.24T vs. DTCCX (479M). VFIAX pays higher dividends than DTCCX: VFIAX (1.32) vs DTCCX (0.00). DTCCX was incepted earlier than VFIAX: DTCCX (25 years) vs VFIAX (24 years). DTCCX is a more actively managed with annual turnover of: 21.98 vs. VFIAX (2.00). DTCCX has a lower initial minimum investment than VFIAX: DTCCX (1000) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 31.72 vs. DTCCX (29.62). VFIAX return over 5 years is better than : 90.47 vs. DTCCX (45.33).
DTCCXVFIAXDTCCX / VFIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years24 years-
Gain YTD21.45119.971107%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets479M1.24T0%
Annual Yield % from dividends0.001.32-
Returns for 1 year29.6231.7293%
Returns for 3 years-1.2330.99-4%
Returns for 5 years45.3390.4750%
Returns for 10 years9.13190.485%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLBD54.491.17
+2.19%
Blue Bird Corp
MPLX44.200.07
+0.16%
Mplx LP
AIP7.45-0.08
-1.06%
Arteris
FFIN38.10-0.74
-1.91%
First Financial Bankshares
TPST1.35-0.06
-4.26%
Tempest Therapeutics